Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Current Taxes (2017 - 2018)

Akebia Therapeutics (AKBA) has disclosed Current Taxes for 2 consecutive years, with $987000.0 as the latest value for Q1 2018.

  • Quarterly Current Taxes changed N/A to $987000.0 in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $987000.0 through Mar 2018, changed N/A year-over-year, with the annual reading at $987000.0 for FY2017, N/A changed from the prior year.
  • Current Taxes for Q1 2018 was $987000.0 at Akebia Therapeutics, roughly flat from $987000.0 in the prior quarter.
  • The five-year high for Current Taxes was $987000.0 in Q4 2017, with the low at $987000.0 in Q4 2017.